12.2.1. Image fusion-guided stereotactic iodine-125 interstitial irradiation of inoperable and recurrent gliomas

J. Julow, Árpád Viola, K. Bálint, G. Szeifert

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Citations (Scopus)

Abstract

Between 1996 and 2004, 27 patients with low grade gliomas (WHO grade I-II), 10 patients with WHO grade III gliomas and 6 patients with glioblastoma multiforme (WHO grade IV) were treated with stereotactic brachytherapy using low-dose rate iodine-125 (125I) isotope seeds at the Department of Neurosurgery, St. John's Hospital, Budapest, Hungary. In all 43 cases, brachytherapy was used for surgically inoperable gliomas: in 32 cases for recurrent gliomas and in 11 cases as a primary treatment. Results of this study suggest that 125I brachytherapy for inoperable and recurrent gliomas is an effective method and offers a chance for longer-term survival.

Original languageEnglish
Title of host publicationRadiosurgery and Pathological Fundamentals
EditorsGyorgy Szeifert, Marc Levivier, Douglas Kondziolka, Dade Lunsford
Pages303-311
Number of pages9
DOIs
Publication statusPublished - Dec 1 2007

Publication series

NameProgress in Neurological Surgery
Volume20
ISSN (Print)0079-6492
ISSN (Electronic)1662-3924

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Julow, J., Viola, Á., Bálint, K., & Szeifert, G. (2007). 12.2.1. Image fusion-guided stereotactic iodine-125 interstitial irradiation of inoperable and recurrent gliomas. In G. Szeifert, M. Levivier, D. Kondziolka, & D. Lunsford (Eds.), Radiosurgery and Pathological Fundamentals (pp. 303-311). (Progress in Neurological Surgery; Vol. 20). https://doi.org/10.1159/000100174